Dec 13, 2023
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $5.08 to $101.52.
The split itself did not change the total investment value.
Altamira Therapeutics Ltd. (OTC:CYTOF) operates in the Biotechnology industry.
Altamira Therapeutics Ltd. company overviewAltamira Therapeutics Ltd.'s most recent stock split was on December 13, 2023. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
Altamira Therapeutics Ltd. (OTC:CYTOF) has split its stock 4 times: a 1-for-10 reverse split on March 14, 2018, a 1-for-20 reverse split on May 1, 2019, a 1-for-20 reverse split on October 25, 2022, and a 1-for-20 reverse split on December 13, 2023.
Altamira Therapeutics Ltd. has split its stock 4 times. This history records 4 reverse splits between March 14, 2018 and December 13, 2023.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Altamira Therapeutics Ltd.'s 1-for-20 reverse split on December 13, 2023, every 20 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Altamira Therapeutics Ltd. has not announced a new split in our records. Its most recent split was on December 13, 2023, 2 years ago. Companies announce splits in advance, and any new OTC:CYTOF split will appear on this page.
Already premium?